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ABSTRACT 
This paper describes a novel assay for measuring the relative extent of peptide 
binding in a large parallel format, and the use of this assay to explore the effects 
of sequence context on the binding of tryptophan (Trp)-containing peptides by 
the synthetic receptor comprising the noncovalent complex between 
cucurbit[8]uril and methyl viologen (i.e., Q8•MV). The extent of quenching of 
Trp fluorescence upon binding to Q8•MV was used to measure the relative 
extent of binding and thus the relative affinities of 104 Trp-containing peptides, 
in parallel, using a fluorescence plate reader. This study resulted in the 
remarkable observation that the identity of the amino acid residues at positions 
adjacent to the Trp binding site has little if any influence on the binding affinity. 
This finding suggests that Q8•MV should be effective for the recognition of Trp 
residues within a broad range of peptide sequences. 
 
Keywords:  cucurbit[8]uril, viologen, tryptophan, peptide, assay  
 2 
1.  Introduction 
Synthetic receptors that can bind to peptides with well-defined affinities and 
specificities would have enormous value for biomedical science and technology. 
The recognition properties of natural protein receptors may depend on specificity 
for a certain type of amino acid residue (e.g., N-recognins, kinases, 
endopeptidases) (1-3) or a certain type of peptide sequence or small protein 
fragment (e.g., antibodies, cell-surface receptors). In any case, it is important to 
understand how the sequence environment (i.e., neighboring residues) 
influences binding. Several synthetic receptors have been shown to bind peptides 
and proteins (4-17), but in the majority of cases, these receptors are known to 
bind to a single type of residue, and the effects of sequence context are 
understood to a limited extent. This paper describes the effects of sequence 
context on the interactions of tryptophan-containing peptides with the synthetic 
receptor, cucurbit[8]uril (Q8), and a method that enables this determination in a 
rapid and parallel fashion. 
Q8 is a tire-shaped, macrocyclic oligomer of bis(methylene)-bridged 
glycoluril, whose hydrophobic inner space and polar rims drive the inclusion of 
cationic, organic, small molecules (18,19). Compared to other cucurbit[n]urils, Q8 
has been studied extensively for its ability to bind two guests simultaneously in 
aqueous solution (20-29). Much of our work with Q8 has focused on the 
molecular recognition of peptides (30-36). We have shown that, when bound to 
methyl viologen (MV) or tetramethyl benzobis(imidazolium) as the first guest, 
Q8 binds to peptides containing tryptophan (Trp) with preference for Trp at the 
N-terminal position (Trp-Gly-Gly; Gly = glycine) versus nonterminal (Gly-Trp-
Gly) or C-terminal (Gly-Gly-Trp) positions (Figure 1) (32, 36). Others have used 
this approach for peptide separation and protein assays (37-40). We are 
interested in the efficacy of peptide recognition across a broad array of sequence 
contexts.  Specifically, we want to know how residues adjacent to the Trp 
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binding site may influence the binding of Q8•MV. For example, can a basic 
residue such as lysine or arginine positioned to the N-terminal side of Trp 
approximate the N-terminal ammonium group that is known to stabilize the 
binding of cucurbit[n]urils to N-terminal aromatic peptides? Do bulky residues 
interfere sterically with binding? Small peptides are straightforward to 
synthesize and characterize in small numbers. Ideally, however, we would like to 
measure and compare the effects of varying the identity of the residues at 
positions neighboring the Trp binding site to all possible amino acids, and thus 
we need to synthesize and screen a library of peptides. 
An interesting characteristic of the Q8•MV•Trp system is its optical sensing 
capabilities. We and others have observed that Trp binding is accompanied by 
the growth of a new charge-transfer absorbance and the quenching of indole 
fluorescence (36, 41). Here we present an assay that uses these supramolecular 
and optical properties to compare in parallel the extent of binding of Q8•MV to a 
library of 104 Trp-containing peptides by comparing the relative extents of 
fluorescence quenching. Remarkably, we observe no significant effect of 
sequence context on Trp binding. 
 
2.  Results and Discussion 
2.1. Design 
The peptide library (Figure 2) was designed such that each peptide contained a 
tryptophan binding site at either an N-terminal or non-terminal position in order 
to account for the expected difference in affinity due to the location of the Trp 
residue (42). The C-terminal position was not investigated because it is the 
lowest affinity site. The N-terminal Trp-containing peptides were tripeptides of 
sequence Trp-Var1-Var2, and the non-terminal Trp-containing peptides were 
pentapeptides of sequence Var1-Var2-Trp-Var3-Var4. The variable (Var) positions 
were each varied among 18 genetically encoded amino acids (43) while holding 
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the other position(s) constant with Ala residues. Ala was chosen as the spacer 
because its beta-methyl group is the largest sidechain fragment that represents 
the structures of the other amino acids (all except Gly). This design resulted in a 
library of 104 peptides (44). The peptide library was synthesized by parallel 
solid-phase synthesis on Rink amide resin (see Supporting Information). 
 
2.2. Parallel Peptide-Binding Assay 
The peptide-binding assay is based on the built-in optical sensing capability 
of the Q8•MV•Trp system, in which the binding of Trp to Q8•MV results in the 
quenching of indole fluorescence with a linear correlation between the observed 
extent of fluorescence quenching and the fraction of indole-containing 
compound bound to Q8•MV (calculated from the known binding affinity (36)). 
This property therefore allows us to estimate the fraction of Trp-containing 
peptides bound to Q8•MV (and thus the binding affinity) by comparing the 
fluorescence intensities of each peptide in the presence and absence of Q8•MV 
(Figure 3).  Here we use this approach in the design of an assay to rapidly screen 
for the relative binding affinity of the library of 104 peptides to the Q8•MV 
complex. Therefore, this approach is amenable to parallel screening of peptide 
binding using a fluorescence plate reader. 
Figure 4 shows the relative fluorescence quenching (45) of the 35 tripeptides 
(Figure 4a) at 13 M and the 69 pentapeptides at 30 M (Figure 4b) in the 
presence of 50 M Q8•MV complex (Figure 4b). In the tripeptide series, the 
extent of fluorescence quenching was in the range 40%-49%, with an average of 
45% and a standard deviation of 2%. In the pentapeptide series, the extent of 
fluorescence quenching was in the range 26%-47%, with an average of 35% and a 
standard deviation of 3%.  In each series, the quenching values are remarkably 
consistent overall, which indicates that the sequence context of the Trp-binding 
site has little influence on the binding affinity. This is particularly true for the 
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tripeptide series, with Trp at the N-terminal position. In the pentapeptide series, 
the range is larger due to the outliers Lys-Ala-Trp-Ala-Ala (1) with 28 % 
quenching, Ala-Lys-Trp-Ala-Ala (2) with 47 % quenching, and Leu-Ala-Trp-Ala-
Ala with 26 % quenching. In order to quantify the range of binding affinities 
represented by the outlier peptides, we measured the equilibrium association 
constant (Ka) values for the sequence isomers 1 and 2 in complex with Q8•MV. 
2.3. Equilibrium Binding Titrations 
Figure 5 shows fluorescence titrations of Q8•MV against a constant 
concentration of peptide for peptides 1 and 2. The Ka values were 6.2 (±0.3) x 103 
M-1 for peptide 1 and 1.7 (±0.1) x 104 M-1 for peptide 2. The small relative binding 
affinity between these two peptides (2.7-fold, 0.6 kcal mol-1) is measurable but 
insignificant, and therefore these results further underscore the minimal effect of 
sequence context on binding to Trp-containing peptides. Using these values in 
addition to the affinity of Q8 for MV (9 x 105 M-1) (36) we calculate the difference 
in the fraction of peptides 1 and 2 bound to Q8•MV to be 17%, which is very 
similar to the observed difference in fluorescence quenching of 19%, as expected.  
These results also demonstrate that the assay is sufficiently sensitive to report 
small differences in binding energies as relatively large differences in the extent 
of fluorescence quenching. 
 
2.4.  Conclusions 
This study explores the effects of sequence context on the binding of Q8•MV 
to Trp-containing peptides. We observe that the identity of the amino acid 
residues at positions adjacent to the Trp-binding site, for both N-terminal and 
non-terminal Trp, have little if any influence on the strength of interaction. This 
result is remarkable given the range of functional groups present in proximity to 
the Q8 portal, including sidechains with ammonium, carboxylate, and 
hydrophobic groups, all of which would be expected to influence the binding 
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affinity via electrostatic, hydrophobic and/or steric interactions. Therefore, 
Q8•MV should be able to bind Trp residues in a broad range of peptide 
sequence contexts with predictable binding affinities. This property may prove 
useful for targeting Trp residues commonly found at hotspots in protein-protein 
interactions (15) and for quantifying surface-exposed tryptophan residues. This 
study also demonstrates a powerful approach to the parallel screening of peptide 
interactions using a synthetic receptor using the convenient measurement of 
fluorescence intensities to estimate relative binding affinities. This approach 
would be compatible with a strategy for altering the binding properties of the 
receptor, Q8•MV, by tailoring the structure of the viologen cofactor. We are 
currently exploring this direction and will report those results in due course. 
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3.  Materials and Methods 
3.1.  Instrumentation 
UV-visible spectra were acquired at 25 °C using an Agilent 8453 
spectrophotometer. Electrospray ionization mass spectrometry (ESI-MS) was 
performed on a Thermo LCQ DECA XP mass spectrometer with an electrospray 
ion source in the positive ion mode.  Fluorescence quenching and titration 
experiments were carried out using a Tecan Infinite M200 Pro plate reader, with 
280 nm excitation and 350 nm emission wavelengths, 5 nm excitation bandwidth, 
20 nm emission bandwidth, and 20 s integration time.  The fluorescence spectra 
of Trp-Ala-Ala and Q8•MV•Trp-Ala-Ala were collected on a PTI QM-4 
spectrophotometer with 280 nm excitation wavelength, 3 nm excitation slit 
width, and 5 nm emission slit width.   
 
3.2.  Materials 
The following compounds were of analytical purity grade and used without 
purification: (L)-Fmoc-Ala-OH, (L)-Fmoc-Arg-(Pbf)-OH, (L)-Fmoc-Asn(Trt)-OH, 
(L)-Fmoc-Asp(OtBu)-OH, (L)-Fmoc-Cys(Trt)-OH, (L)-Fmoc-Glu(OtBu)-OH, (L)-
Fmoc-Gln(Trt)-OH, (L)-Fmoc-Gly-OH, (L)-Fmoc-His(Trt)-OH, (L)-Fmoc-Ile-OH, 
(L)-Fmoc-Leu-OH, (L)-Fmoc-Lys(Boc)-OH, (L)-Fmoc-Met-OH, (L)-Fmoc-Phe-OH, 
(L)-Fmoc-Pro-OH, (L)-Fmoc-Ser(tBu)-OH, (L)-Fmoc-Thr(tBu)-OH, (L)-Fmoc-
Trp(Boc)-OH, (L)-Fmoc-Tyr(tBu)-OH, (L)-Fmoc-Val-OH, and O-(benzotriazol-1-
yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HBTU)  (Peptides 
International); biotech-grade dimethyl formamide (DMF), diisopropylethylamine 
(DIEA), triisopropylsilane (TIS), trifluoroacetic acid (TFA), piperidine, anhydrous 
dichloromethane (DCM), and HPLC-grade acetonitrile (Sigma-Aldrich); and 
monobasic and dibasic sodium phosphate (VWR). Cucurbit[8]uril (Q8) was 
synthesized according to a published procedure (46). Water was obtained from a 
Barnstead Nanopure Infinity water system (18 MΩ cm). 
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A stock solution of 1.0 M sodium phosphate buffer was adjusted to pH 7.0 
and sterile filtered. 10 mM sodium phosphate buffer was made as needed by 
diluting the 1.0 M stock and adjusting to pH 7.0. The concentration of methyl 
viologen was determined by UV spectroscopy (ε257 = 20,400 M-1cm-1).  The 
concentration of Q8 was standardized by calorimetric titration with methyl 
viologen. 
 
3.3.  Peptide Synthesis 
Parallel fmoc solid-phase synthesis was carried out using SynPhase Rink amide 
Lantern resins from Mimotopes on 8 μmol scale.  The resins were mounted to 
pins in an 8 x 12 array (i.e., the “rack of resins”) to match the spacing of a 
standard 96-well plate.  Fmoc deprotection was accomplished by adding 500 μL 
of 20% piperidine (v/v) in dimethylformamide (DMF) into each well of a 96 well 
deep-well block (Hamilton Research), and then seating the rack of resins into the 
wells of the block and allowing the reaction to shake at 120 RPM for 1 hour 25 °C 
in an orbital shaker (e.g., a shaking bio-incubator). The rack of resins was then 
rinsed thoroughly according to the following procedure:  1) two baths of DMF 
and dichloromethane (DCM) were set up; 2) the rack of resins was rinsed 
thoroughly and sequentially by dipping first into the two DMF baths, and then 
into the two DCM baths, with gentle flicking of the rack between each rinse to 
remove excess solution; and 3) the rack of resins was removed and allowed to air 
dry for approximately 20 minutes.   
To prepare benzotriazoyl-activated amino acid solutions for coupling, we 
used 12 equivalents (96 μmol) of fmoc amino acid, 12 equivalents (96 μmol) of di-
isopropyl ethylamine (DIEA), and 10 equivalents (80 μmol) of HBTU (based on a 
limiting quantity of 8 mol resin) dissolved in 0.5 mL of DMF.  Amino acid 
solutions were scaled to the number of couplings needed per amino acid in the 
entire library so that only one stock solution of each amino acid needed to be 
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prepared. The coupling reaction was accomplished by adding 0.5 mL of the 
activated amino acid solution into a well of a clean 96-well deep-well block and 
then seating the resin rack into the block.  The reaction shook (120 RPM) for 3 
hours at 25 ºC, and the resins were then rinsed as described above.   
Cycles of deprotection and coupling continued in this manner until the 
desired sequence was obtained. After the final fmoc deprotection, the resins were 
rinsed as described above. Cleavage of the peptides from the resins was carried 
out by adding 600 μL of cleavage solution (95% TFA, 2.5% H20, 2.5% TIS), into 
each well of a clean 96-well deep-well block, seating the resin rack into it, and 
letting the reactions shake at 120 RPM for 1 hour at 25 ºC. The resin rack was 
removed, and the cleavage mixture was evaporated overnight with steady 
airflow over the plate. After the TFA was removed completely, 800 μL of 
nanopure water was added to each well, and the block was heated at 60 ºC for 30 
min to dissolve the peptides. The peptide solutions were transferred to 1.5 mL 
Eppendorf tubes and lyophilized to dryness.  The dry peptides were 
resuspended in 1.0 mL of 10 mM phosphate buffer, heated for 15 minutes at 60 
ºC, and sonicated if necessary to solubilize the peptides. A random subset of six 
peptides was tested for purity, quantity, and identity (See Supporting 
Information). The average purity, as determined by analytical HPLC, was 78%. 
The average concentration, as determined by UV-spectroscopy (280 = 5500 M-1 
cm-1) was 2.1 mM for the tripeptides and 4.8 mM for the pentapeptides, and thus 
the peptide recoveries from synthesis were 26% for the tripeptides and 60% for 
the pentapeptides. The identities of the peptides were confirmed by ESI-MS. The 
peptide solutions were stored at 4 C. 
 
3.4.  Fluorescence Quenching Experiments 
Q8•MV solutions were prepared by dissolving MV in 10 mM sodium phosphate 
buffer, pH 7.0, and determining the concentration of the solution by UV 
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spectroscopy (ε257 = 20,400 M-1cm-1).  This solution was adjusted to 100 μM in the 
same buffer and added to an equimolar quantity of dry Q8.  The Q8•MV mixture 
was solubilized by mixing and brief ultrasonication followed by heating at 60 °C 
for 15-20 minutes.  The resulting colorless solution was cooled to room 
temperature and sterile-filtered (0.4 m, Teflon).   
Fluorescence experiments were carried out in Corning 96-well, black, flat-
bottomed plates.  Peptides sample solutions were prepared by mixing 50 μL of 
peptide stock solution with 50 μL of 10 mM phosphate buffer.  Peptide + Q8•MV 
solutions were prepared by mixing 50 μL of peptide stock solution with 50 μL of 
100 μM Q8•MV solution. The peptide stock solutions were 26 μM for tripeptides 
and 60 μM for pentapeptides. Therefore, the final concentrations were 13 μM 
tripeptide or 30 μM pentapeptide, and 50 μM Q8•MV for samples that contain 
Q8•MV. The solutions were mixed by pipetting before reading the fluorescence 
intensity on a fluorescence plate reader. The extent of fluorescence quenching 
(%Quenched) was determined as the fraction of fluorescent emission intensity (F) 




    Eq. 1 
 
3.5.  Fluorescence Titrations 
Fluorescence titrations were carried out on peptides 1 and 2.  The peptides were 
quantified UV spectroscopy (280 = 5500 M-1 cm-1). In the final samples for 
measurement, the concentration of peptide was held constant at 0.121 mM for 
peptide 1 and 0.206 mM for peptide 2, while the concentration of Q8•MV was 
varied over the range 0-1.4 mM.  Fluorescence intensity values were obtained 
using the plate reader and plotted versus the total peptide concentration. Each 
plot was fit to a simple binary equilibrium model using a nonlinear regression to 
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Figure 1.  (top) Equilibria involved in the formation of the Q8•MV•Trp complex. 
(bottom) Chemical formulas of the constituents. 
Figure 2.  Library of (left) tripeptides and (right) pentapeptides used in this 
study. The variable (Var) positions were varied to 18 amino acids (the canonical 
20 minus Trp and Cys). 
Figure 3.  Fluorescence spectral overlay of Trp-Ala-Ala in the absence and 
presence of Q8•MV. All species were at 50 M in a buffer of 10 M sodium 
phosphate, pH 7.0. 
Figure 4.  Extent of fluorescence quenching of samples containing (a) 13 M 
tripeptide or (b) 30 M pentapeptide in the presence of 50 M Q8•MV at 25 C in 
10 mM sodium phosphate, pH 7.0. The identity of the variable position is 
indicated along the Y-axis, and the location of the variable positions within the 
peptides are indicated by the legends. Average values of at least three 
experiments are plotted. Error bars indicate the standard deviation. 
Figure 5.  Titration of Q8•MV against a constant concentration of peptides 1 
(0.121 mM) and 2 (0.206 mM). Relative fluorescence emission intensity values are 
plotted. The line indicates the best fit to binary equilibrium binding model. 
Equilibrium association constant values, derived from the fits, are shown. 
 
